Lung Large Cell Neuroendocrine Carcinoma: An Analysis of Patients from the Surveillance, Epidemiology, and End-Results (SEER) Database.
CONCLUSIONS LCNEC is a rare lung cancer subtype with a dismal prognosis. Primary surgical treatment has significant survival benefits, even for stage IV patients. The optimal treatment strategies for lung LCNEC require further investigation.
PMID: 31095532 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Biomedical Science | Brain | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Databases & Libraries | Epidemiology | Lung Cancer | Neurology | Neuroscience | Neurosurgery | Research | Science | Statistics | Study